Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited due to allegations of securities law violations, encouraging affected investors to come forward before the April 13, 2026 deadline for lead plaintiff applications [2][5]. Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives made false and misleading statements, failing to disclose involvement in a fraudulent stock promotion scheme and the use of offshore accounts for share dumping [5]. - Specific allegations include the omission of information regarding false rumors and artificial trading activity that inflated the stock price, leading to materially misleading public statements about the company's business and prospects [5]. Group 2: Stock Performance - Pomdoctor's share price experienced a significant decline of approximately 24%, dropping from about $0.50 per share on December 10, 2025, to around $0.38 per share on December 11, 2025, amid increased volatility and investor concerns about its financial performance [6]. Group 3: Legal Proceedings - The role of the lead plaintiff in the class action is to represent the interests of the class members, with any member able to apply for this role or remain an absent class member without affecting their ability to recover [7]. - Faruqi & Faruqi encourages individuals with information regarding Pomdoctor's conduct to contact the firm, including whistleblowers and former employees [8].
POM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026